RxSearch
HomeSearchRxCUI 1294621: Brands

NDC properties for "Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule" (RxCUI 1294621)

About this data

The tables show NDC propoerties for Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule with the RxCUI 1294621

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product

Details for Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule (RxCUI 1294621)

MMSL_CODEBD19736
NDANDA050786
RxCUI1294621
SPL_SET_ID5cdacbf5-67be-42eb-bd54-8acc32ea1abc
SPL_SET_ID7fe5d2db-c59d-4e15-acd7-f9df8eca45aa
SPL_SET_IDa762e164-b390-4e8c-bd46-bf6c31eeb486
Prescribable SynonymPYLERA 140 MG / 125 MG / 125 MG Oral Capsule
RXNAV_STRPylera (bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule
RxNorm Namebismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera]
RxNorm SynonymPylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule
Tallman Synonymbismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera]
Tallman SynonymPylera (bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule
Related queriesInteractions (for RxCUI 1294621)



NDC Properties

NDC Item 58914060120

NDC 958914-601
NDC 1058914-601-20
NDC Item58914060120
Packaging1 BLISTER PACK in 1 BOX (58914-601-20) / 120 CAPSULE in 1 BLISTER PACK
COLORTEXTwhite(Opaque white)
ColorC48325 __
FDA SPL set id746906
Imprint codeAptalis;BMT
LabelerAllergan, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2013-08-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 58914-601

NDC Item 58914060121

NDC 958914-601
NDC 1058914-601-21
NDC Item58914060121
Packaging1 BOTTLE in 1 BOX (58914-601-21) / 120 CAPSULE in 1 BOTTLE
COLORTEXTwhite(Opaque white)
ColorC48325 __
FDA SPL set id746906
Imprint codeAptalis;BMT
LabelerAllergan, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2013-08-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 58914-601

NDC Item 61269038012

NDC 961269-380
NDC 1061269-380-12
NDC Item61269038012
Packaging10 BLISTER PACK in 1 BOX (61269-380-12) / 12 CAPSULE in 1 BLISTER PACK
COLORTEXTWHITE(opaque)
ColorC48325 __
FDA SPL set id799010
Imprint codeAptalis;BMT
LabelerH2-Pharma, LLC
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2023-10-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 61269-380

NDC Item 58914060120

NDC 958914-601
NDC 1058914-601-20
NDC Item58914060120
Packaging1 BLISTER PACK in 1 BOX (58914-601-20) / 120 CAPSULE in 1 BLISTER PACK
COLORTEXTwhite(Opaque white)
ColorC48325 __
FDA SPL set id746906
Imprint codeAptalis;BMT
LabelerAllergan, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2013-08-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 58914-601

NDC Item 58914060121

NDC 958914-601
NDC 1058914-601-21
NDC Item58914060121
Packaging1 BOTTLE in 1 BOX (58914-601-21) / 120 CAPSULE in 1 BOTTLE
COLORTEXTwhite(Opaque white)
ColorC48325 __
FDA SPL set id746906
Imprint codeAptalis;BMT
LabelerAllergan, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2013-08-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 58914-601

NDC Item 61269038012

NDC 961269-380
NDC 1061269-380-12
NDC Item61269038012
Packaging10 BLISTER PACK in 1 BOX (61269-380-12) / 12 CAPSULE in 1 BLISTER PACK
COLORTEXTWHITE(opaque)
ColorC48325 __
FDA SPL set id799010
Imprint codeAptalis;BMT
LabelerH2-Pharma, LLC
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2023-10-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 61269-380

NDC Item 58914060120

NDC 958914-601
NDC 1058914-601-20
NDC Item58914060120
Packaging1 BLISTER PACK in 1 BOX (58914-601-20) / 120 CAPSULE in 1 BLISTER PACK
COLORTEXTwhite(Opaque white)
ColorC48325 __
FDA SPL set id746906
Imprint codeAptalis;BMT
LabelerAllergan, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2013-08-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 58914-601

NDC Item 58914060121

NDC 958914-601
NDC 1058914-601-21
NDC Item58914060121
Packaging1 BOTTLE in 1 BOX (58914-601-21) / 120 CAPSULE in 1 BOTTLE
COLORTEXTwhite(Opaque white)
ColorC48325 __
FDA SPL set id746906
Imprint codeAptalis;BMT
LabelerAllergan, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2013-08-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 58914-601

NDC Item 61269038012

NDC 961269-380
NDC 1061269-380-12
NDC Item61269038012
Packaging10 BLISTER PACK in 1 BOX (61269-380-12) / 12 CAPSULE in 1 BLISTER PACK
COLORTEXTWHITE(opaque)
ColorC48325 __
FDA SPL set id799010
Imprint codeAptalis;BMT
LabelerH2-Pharma, LLC
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2023-10-01
Marketing statusACTIVE
NDANDA050786
Score1
ShapeC48336
Size22 mm
Related queriesProperties for NDC 9 61269-380